Hypertension in the ElderlyAnthony Amery, Jan Staessen The Handbook of Hypertension series is recognized as an authoritative source of information and reviews on clinical and research aspects of high blood pressure, with each volume complete and separate in its own right. The series has resulted from lengthy discussions with clinicians and scientists, and has proven to be of interest to many different groups including clinical investigators, medical specialists, house officers, general practitioners, pharmacologists, pharmacists, biological scientists, physiologists and epidemiologists. This volume addresses the topic of hypertension in the elderly. With an aging population and a very high prevalence of hypertension and vascular disease in people over 60 years of age, the timing is appropriate. This volume presents a comprehensive review of the field, including aging and the circulation, the epidemiology of hypertension in the elderly, treatment alternatives based on drug and non-drug approaches, and the results of major intervention trials. |
Contents
Introduction xiii | 1 |
Aging and the baroreflex | 24 |
Alterations in reflex control of the circulation associated with aging | 39 |
Copyright | |
17 other sections not shown
Common terms and phrases
action activity agents alterations antihypertensive appears arterial associated average blockers blood flow blood pressure calcium antagonists cardiac output cardiovascular cause central changes circulation Clin clinical clonidine combination compared compliance concentration coronary deaths decrease diastolic diastolic blood pressure disease diuretic doses drugs effects elderly hypertensive elderly patients essential hypertension evidence excretion factors failure fall filtration findings function glucose heart hypertensive patients impaired important incidence increased influence kidney left ventricular less levels lower mean measurements mechanisms Medical mild mmHg morbidity mortality myocardial infarction nervous norepinephrine normal observed occur older peripheral Pharmacol placebo plasma population present prevalence randomized rats receptor reduced renal renin reported resistance response risk sensitivity shown side-effects significant similar sodium stroke subjects suggest sympathetic systolic systolic hypertension Table therapy treated treatment trial vascular volume young younger